Manchester Biomedical Research Centre PhD studentships
The NIHR Manchester Biomedical Research Centre (MBRC) is a partnership between Manchester University Foundation Trust (MFT) and The University of Manchester.
The MBRC brings together expertise from across the city to accelerate new discoveries through translational research that will improve health. The BRC delivery partners are:
- Manchester University Foundation Trust (MFT)
- Salford Royal NHS Foundation Trust
- The Christie Hospital NHS Foundation Trust (The Christie)
- The University of Manchester
Supported by the Manchester Academic Health Science Centre (MAHSC), the MBRC will help clinicians to move towards a more proactive approach to medicine by applying the P4 principles:
- Prevent disease
- Predict disease progression
- Personalise treatment pathways
- empower patients to Participate in their healthcare
The MBRC will run for five years from 1 April 2017 to fund MBRC research posts and biomedical studies in the following areas:
- musculoskeletal diseases
- hearing health
- respiratory diseases
Visit the NIHR Manchester Biomedical Research Centre website.
To see a list of the projects available under this studentship, view our pre-filtered project search.
How to apply
If you are interested in applying for a project, you are encouraged to contact the Primary Supervisor directly to discuss your application and submit an online application to The University of Manchester.
On the University online application form, please select 'Postgraduate Research' and 'Manchester BRC' for the programme. See the how to apply page for details of the application process.
You should include all supporting documents when you submit your application; any documents not available at the time of submission can be emailed separately.
Applicants must be from the UK/EU and funding covers fees for three years, as well as an annual stipend (tax-free).
Applicants are expected to hold (or be about to obtain) a minimum Upper Second class honours degree in a relevant subject area.
Applicants must be from the UK/EU and funding covers fees/salary (an appropriate amount in line with the applicant's current salary and grade) for three years.
Candidates will hold a medical degree and show evidence of interest in the project area. Candidates are expected to hold a postgraduate degree, such as Masters, and have a track record in clinical research.
Applications will close on 2 February 2018.
If you have any queries about the funding, eligibility or application process, please contact the Doctoral Academy Admissions team at email@example.com.
About the MBRC delivery partners
Manchester University Foundation Trust is a leading provider of specialist healthcare services in Manchester, treating more than a million patients every year.
Its nine specialist hospitals (Manchester Royal Infirmary, Saint Mary's Hospital, Royal Manchester Children's Hospital, Manchester Royal Eye Hospital, University Dental Hospital of Manchester, Trafford General, Wythenshawe Hospital, Withington Community Hospital, and Altrincham Hospitals) and community services are home to hundreds of world-class clinicians and academic staff committed to finding patients the best care and treatments.
Find out more about the Manchester University Foundation Trust.
The University of Manchester, a member of the prestigious Russell Group, is the UK's largest single-site university with 38,600 students.
It has 20 academic schools and hundreds of specialist research groups undertaking pioneering, multi-disciplinary teaching and research of worldwide significance.
Cancer is one of Manchester's research beacons – examples of pioneering discoveries, interdisciplinary collaboration and cross-sector partnerships that are tackling some of the biggest questions facing the planet.
The University is one of the country's major research institutions, rated fifth in the UK in terms of research power (REF 2014), and has had no fewer than 25 Nobel laureates either work or study there. The University had an annual income of just over £1 billion in 2014/15.
Manchester Academic Health Science Centre (MAHSC) is one of six academic health science centres in England.
Its partners are The University of Manchester, Central Manchester University Hospitals NHS Foundation Trust, the Manchester Mental Health and Social Care Trust, Salford Clinical Commissioning Group, Salford Royal NHS Foundation Trust, The Christie NHS Foundation Trust, and University of South Manchester NHS Foundation Trust.
The Christie opened in 1901 and is now one of Europe's leading cancer centres and the largest single-site centre in Europe. It has one of the largest radiotherapy departments in the world, as well as centres in Oldham and Salford. It also houses the UK's largest brachytherapy service.
The Christie delivers chemotherapy treatment through the largest chemotherapy unit in the UK, as well as via 10 other sites, a mobile chemotherapy unit and in patients' homes. The Christie is ranked as the 9th most technologically advanced cancer centre in the world and the top centre outside North America.
Our NIHR Clinical Research Facility is a large, high quality, dedicated clinical research environment where our patients can participate in complex and early phase clinical trials. Around 600 clinical trials may be taking place at any one time. New developments include the UK's first NHS high energy proton beam therapy service, due to start treating patients in 2018.
The Christie's School of Oncology provides undergraduate education, clinical professional and medical education – the first of its kind in the UK.
Salford Royal NHS Foundation Trust aims to be the safest organisation in the NHS through providing safe, clean and personal care to every patient, every time.
The Trust is an integrated provider of hospital, community and primary care services, including the University Teaching Trust.
Salford Royal's team of 7,000 staff provide local services to the City of Salford and specialist services to Greater Manchester and beyond. It is an Outstanding Trust – the first Trust in the north of England to achieve the highest rating given by the Care Quality Commission.
The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research.
Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research.
The NIHR plays a key role in the Government's strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence and systems represent the most integrated health research system in the world.